Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
The Journal of Biological Chemistry|March 4, 2003
The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced signaling cascadesHisanori Takenobu, Ayano Yamazaki, Michinari Hirata, et al.European Journal of Cell Biology|May 31, 2022
The PRC2 molecule EED is a target of epigenetic therapy for neuroblastomaDilibaerguli Shaliman, Hisanori Takenobu, Ryuichi P Sugino, et al.Genes to Cells : Devoted to Molecular & Cellular Mechanisms|January 21, 2026
Coexpression of MYCN and ALK Induces Neuroblastoma-Like Tumors From Human iPS Cell-Derived Cranial Neural Crest CellsTianyuan Shi, Kyosuke Mukae, Maya Shindo, et al.Anticancer Research|January 12, 2007
Up-regulated expression of the uridine phosphorylase gene in human gastric tumors is correlated with a favorable prognosisKiyoko Kawamura, Nobuhiro Takiguchi, Akihiko Wada, et al.Immunology|January 21, 2006
The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effectsOsamu Shimozato, Shin-ichi Ugai, Masako Chiyo, et al.Cancer Science|May 25, 2010
Polycomb group molecule PHC3 regulates polycomb complex composition and prognosis of osteosarcomaShintaro Iwata, Hisanori Takenobu, Hajime Kageyama, et al.European Journal of Cancer (Oxford, England : 1990)|February 25, 2014
Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN/ataxia telangiectasia mutated/p53 pathwayYohko Yamaguchi, Hisanori Takenobu, Miki Ohira, et al.European Journal of Cancer (Oxford, England : 1990)|July 2, 2010
HDM2 impairs Noxa transcription and affects apoptotic cell death in a p53/p73-dependent manner in neuroblastomaYun Shi, Hisanori Takenobu, Kenji Kurata, et al.Oncology Reports|September 6, 2005
Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cellsLing Yu, Hisanori Takenobu, Osamu Shimozato, et al.Anticancer Research|January 30, 2022
Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial CarcinomaRyo Kurashina, Kiyohiro Ando, Masaharu Inoue, et al.Pageof 3